levosemotiadil

Known as: (-)-(S)-2-(5-Methoxy-2-(3-(Methyl(2-(3,4-(Methylenedioxy)Phenoxy)Ethyl)Amino)Propoxy)Phenyl)-4-Methyl-2H-1,4-Benzothiazin-3(4H)-One 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1997-2003
01219972003

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2003
2003
Anti-arrhythmic compounds with multiple actions reduce arrhythmic death risk in post-myocardial infarction (MI) patients. Sudden… (More)
Is this relevant?
Review
2001
Review
2001
This review article demonstrates the applicability of high-performance frontal analysis (HPFA) to the enantioselective drug… (More)
Is this relevant?
1999
1999
High-performance frontal analysis (HPFA) was used to investigate the binding properties of human alpha(1)-acid glycoprotein (AGP… (More)
Is this relevant?
1997
1997
An on-line frontal analysis HPLC system was developed for the determination of the unbound concentrations of semotiadil, a new… (More)
Is this relevant?
1997
1997
The enantioselective local disposition of semotiadil (R-enantiomer) and levosemotiadil (S-enantiomer) in rat liver was… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • table 2
Is this relevant?